Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Personalized Radiotherapy for Biochemical Recurrence of Prostate Cancer After Prostatectomy: a Randomized Phase III Study.

NCT04858880 is registered in ClinicalTrials.gov with Lund University Hospital as lead sponsor.

NCT NCT04858880
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04858880 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Personalized Radiotherapy for Biochemical Recurrence of Prostate Cancer After Prostatectomy: a Randomized Phase III Study.
Lead sponsor
Lund University Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
April 9, 2021
Completion date
April 30, 2030
Enrollment
374 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer